Evangelisches Klinikum Bethel

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Heart failure1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial

Phase

• Phase 31 trial

Status

• Completed3 trials
• Recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Jena University Hospital1 trial
• Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
• MicroPort CRM1 trial
• University of Heidelberg Medical Center1 trial

Running trials

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Source

• Recruiting

  Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

  NCT04298723· Jena University Hospital· Source

  Contact: Wladimir Tschichow, Dr.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Lung cancer1 recruiting

Closed trials

• Completed

  Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

  NCT05804032· Phase 3· University of Heidelberg Medical Center· Source

• Completed

  An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

  NCT04941768· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Source

• Completed

  Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

  NCT04590144· MicroPort CRM· Source